The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Europe Protein A Resins Market Segmented By Product Type, Applications, End Users, Matrix Type And By Region - Industry Analysis, Size, Share, Growth Trends And Forecasts 2016-2020

Europe Protein A Resins Market Segmented By Product Type, Applications, End Users, Matrix Type And By Region - Industry Analysis, Size, Share, Growth Trends And Forecasts 2016-2020

Publishing Date : Dec, 2016

License Type :
 

Report Code : 429442

No of Pages : 183

Synopsis
The Europe Protein A Resins Market was worth $105.2 million in 2016 and estimated to be growing at a CAGR of 9.11%, to reach $162.7 million by 2021. The market is showing evident potential in the mentioned forecast period. Increasing research and development activities on monoclonal antibodies is expected to drive sales of Protein A resins in the future.
European market for Protein A Resins is driven by factors such as growing demand for biosimilars and increasing investments into the research and development of biosimilar products while factors such as increasing awareness about alternate methods to purify monoclonal antibodies and high cost of these products are anticipated to hamper the growth of Protein A Resins market.
European market for Protein A resin is segmented by product type, application, matrix type and end user. Based on product the market is further segmented into Natural Protein A Resin and Recombinant Protein A Resin. Recombinant Protein A segment is estimated to be the fastest growing product segment. By application protein A Resin market is analysed as Immuno precipitation and Antibody Purification. Immuno precipitation segment is estimated to be the fastest growing. Based on Matrix type Europe Protein A Resin market is segmented into Glass or Silica, Agarose and Organic Polymer. Among the matrix type agarose accounts for the largest share and is estimated to continue its strong share during the forecast period. By end user the market is segmented into Biopharmaceutical Manufacturers, Clinical Research Laboratories and Academic Institutions.
Geographically Europe Protein A resin market is analysed under various regions namely United Kingdom, Germany, Italy, Spain, France, Russia and Poland. Within Europe, United Kingdom is largest market for Protein A resins whereas Spain is estimated to be the fastest growing region.
Some of the major companies covered in the report are GE Healthcare, Repligen Corporation, Novasep, Tosoh Bioscience, GenScript, Thermo Fisher Scientific, EMD Millipore and Expedeon Ltd.

Geographical Area
UK, Germany, France, Italy, Spain, Russia, Poland, Rest of Europe
Index
1 INTRODUCTION
1.1 MARKET DEFINITION
1.2 KEY DELIVERABLES OF THE STUDY
1.3 BASE CURRENCY, BASE YEAR, AND FORECAST PERIOD
1.4 GENERAL STUDY ASSUMPTIONS
2 RESEARCH APPROACH AND METHODOLOGY
2.1 INTRODUCTION
2.1.1 SIZE ESTIMATION
2.1.2 FORECASTING METHODOLOGY
2.2 RESEARCH PHASES
2.2.1 SECONDARY RESEARCH
2.2.2 PRIMARY RESEARCH
2.2.3 ECONOMETRIC MODELLING
2.2.4 EXPERT VALIDATION
2.3 ANALYSIS DESIGN
2.4 STUDY TIMELINE
3 OVERVIEW
3.1 EXECUTIVE SUMMARY
3.2 KEY INFERENCES
4 MARKET DYNAMICS
4.1 MARKET DRIVERS
4.1.1 HIGH APPROVAL RATES OF MONOCLONAL ANTIBODIES
4.1.2 GROWING DEMAND FOR BIOSIMILARS
4.1.3 INCREASING INVESTMENTS IN BIOSIMILARS’ R&D
4.2 MARKET RESTRAINTS
4.2.1 ALTERNATE METHODS TO PURIFY MONOCLONAL ANTIBODIES
4.2.2 HIGH COSTS ASSOCIATED WITH PROTEIN RESINS
4.3 MARKET OPPORTUNITIES
4.3.1 PROCESS INTENSIFICATION
4.3.2 REUSE OF PROTEIN A RESIN
4.4 MARKET CHALLENGES
4.4.1 NEED FOR CONTIONOUS EVOLUTION AND ADAPTATION
4.4.2 PERFORMANCE AFFECTING FACTORS
5 MARKET SEGMENTATION
5.1 INTRODUCTION
5.2 EUROPE PROTEIN A RESINS MARKET, BY PRODUCT TYPE
5.3 EUROPE PROTEIN A RESINS MARKET, BY MATRIX TYPE
5.4 EUROPE PROTEIN A RESINS MARKET, BY APPLICATION
5.5 EUROPE PROTEIN A RESINS MARKET, BY END USER
6 GEOGRAPHICAL ANALYSIS
6.1 INTRODUCTION
6.2 UNITED KINGDOM PROTEIN A RESINS MARKET
6.2.1 United kingdom Protein A Resins Market, By Product Type
6.2.2 United kingdom Protein A Resins Market, By Matrix Type
6.2.3 United kingdom Protein A Resins Market, By Application
6.2.4 United kingdom Protein A Resins Market, By End User
6.3 GERMANY PROTEIN A RESINS MARKET
6.3.1 Germany Protein A Resins Market, By Product Type
6.3.2 Germany Protein A Resins Market, By Matrix Type
6.3.3 Germany Protein A Resins Market, By Application
6.3.4 Germany Protein A Resins Market, By End User
6.4 SPAIN PROTEIN A RESINS MARKET
6.4.1 Spain Protein A Resins Market, By Product Type
6.4.2 Spain Protein A Resins Market, By Matrix Type
6.4.3 Spain Protein A Resins Market, By Application
6.4.4 Spain Protein A Resins Market, By End User
6.5 ITALY PROTEIN A RESINS MARKET
6.5.1 Italy Protein A Resins Market, By Product Type
6.5.2 Italy Protein A Resins Market, By Matrix Type
6.5.3 Italy Protein A Resins Market, By Application
6.5.4 Italy Protein A Resins Market, By End User
6.6 FRANCE PROTEIN A RESINS MARKET
6.6.1 France Protein A Resins Market, By Product Type
6.6.2 France Protein A Resins Market, By Matrix Type
6.6.3 France Protein A Resins Market, By Application
6.6.4 France Protein A Resins Market, By End User
6.7 RUSSIA PROTEIN A RESINS MARKET
6.7.1 Russia Protein A Resins Market, By Product Type
6.7.2 Russia Protein A Resins Market, By Matrix Type
6.7.3 Russia Protein A Resins Market, By Application
6.7.4 Russia Protein A Resins Market, By End User
6.8 POLAND PROTEIN A RESINS MARKET
6.8.1 Poland Protein A Resins Market, By Product Type
6.8.2 Poland Protein A Resins Market, By Matrix Type
6.8.3 Poland Protein A Resins Market, By Application
6.8.4 Poland Protein A Resins Market, By End User
6.9 REST OF EUROPE PROTEIN A RESINS MARKET
6.9.1 Rest of Europe Protein A Resins Market, By Product Type
6.9.2 Rest of Europe Protein A Resins Market, By Matrix Type
6.9.3 Rest of Europe Protein A Resins Market, By Application
6.9.4 Rest of Europe Protein A Resins Market, By End User
7 STRATEGIC ANALYSES
7.1 PESTLE ANALYSIS
7.1.1 POLITICAL
7.1.2 ECONOMICAL
7.1.3 SOCIAL
7.1.4 TECHNOLOGICAL
7.1.5 LEGAL
7.1.6 ENVIRONMENTAL
7.2 PORTER’S FIVE FORCES ANALYSES
7.2.1 THREAT OF NEW ENTRANTS
7.2.2 THREAT OF SUBSTITUTES
7.2.3 BARGAINING POWER OF SUPPLIERS
7.2.4 BARGAINING POWER OF BUYERS
7.2.5 COMPETITVE RIVALRY
8 COMPANY PROFILES
8.1 GE HEALTHCARE
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financials (in USD Million)
8.1.4 Recent Developments
8.1.5 SWOT Analysis
8.1.6 Analyst View
8.2 REPLIGEN CORPORATION
8.2.1 Overview
8.2.2 Product Analysis
8.2.3 Financials (in USD Million)
8.2.4 Recent Developments
8.2.5 SWOT Analysis
8.2.6 Analyst View
8.3 THERMO FISHER SCIENTIFIC
8.3.1 Overview
8.3.2 Product Analysis
8.3.3 Financials (USD Millions)
8.3.4 Recent Developments
8.3.5 SWOT Analysis
8.3.6 Analyst view
8.4 MERCK MILLIPORE
8.4.1 Overview
8.4.2 Product Analysis
8.4.3 Financials (USD Million)
8.4.4 Recent Developments
8.4.5 SWOT Analysis
8.4.6 Analyst View
8.5 GENSCRIPT BIOTECH CORPORATION
8.5.1 Overview
8.5.2 Product Analysis
8.5.3 Financials
8.5.4 SWOT Analysis
8.5.5 Analyst View
8.6 BIO-RAD LABORATORIES
8.6.1 Overview
8.6.2 Product Analysis
8.6.3 Financials (USD Million)
8.6.4 SWOT Analysis
8.6.5 Analyst View
8.7 PUROLITE CORPORATION
8.7.1 Overview
8.7.2 Product Analysis
8.7.3 Recent Developments
8.7.4 Analyst View
8.8 NOVASEP HOLDING S.A.S
8.8.1 Overview
8.8.2 Product Analysis
8.8.3 Analyst View
8.9 EXPEDEON LTD
8.9.1 Overview
8.9.2 Product Analysis
8.9.3 Recent Developments
8.9.4 Analyst View
8.1 BIOMEDAL S.L
8.10.1 Overview
8.10.2 Product Analysis
8.10.3 Analyst View
9 COMPETETIVE LANDSCAPE
9.1 COMPANY SHARE ANALYSIS
9.2 MERGERS & ACQUISITIONS
9.3 COLLABORATIONS, AGREEMENTS & EXPANSIONS
9.4 NEW PRODUCT LAUNCHES
10 MARKET OUTLOOK

Published By : Market Data Forecast

Why ‘The Market Reports’